K. Loughran

Trial-related discrimination in HIV vaccine clinical trials.

M. Allen, H. Israel, S. Erb, 2001, AIDS research and human retroviruses.

A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers.

S. Kochhar, J. Excler, P. Fast, 2009, AIDS research and human retroviruses.

A Phase I Double Blind, Placebo-Controlled, Randomized Study of a Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults

J. Excler, P. Fast, P. Hayes, 2012, PloS one.

Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa

R. Koup, E. Karita, G. Nabel, 2010, PloS one.

Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+ T-Cell Epitopes

Lucy Dorrell, Andrew J. McMichael, Jill Gilmour, 2006, Journal of Virology.

A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers.

S. Kochhar, J. Excler, P. Fast, 2009, AIDS research and human retroviruses.